Immune Pharmaceuticals And STC Biologics Announce Strategic Partnership To Accelerate The Development of NanomAbs

By: via Benzinga
Immune Pharmaceuticals Inc. (NASDAQ: IMNP), a clinical stage bio-pharmaceutical company with a first-in-class monoclonal antibody, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.